Sir Charles Gairdner Hospital is a teaching hospital in Nedlands, Western Australia. Opened in 1958 as the Perth Chest Hospital and later named in honour of Sir Charles Gairdner, governor of Western Australia from 1951 to 1963, it is part of the Queen Elizabeth II Medical Centre.

During the past decade, Sir Charles Gairdner Hospital conducted 123 clinical trials. In the 10-year time frame, 123 clinical trials started and 52 clinical trials were completed, i.e. on average, 42.3% percent of trials that started reached the finish line to date. In the past 5 years, 60 clinical trials started and 32 clinical trials were completed. i.e. 53.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sir Charles Gairdner Hospital" #1 sponsor was "Trans Tasman Radiation Oncology Group" with 16 trials, followed by "Gilead Sciences" with 15 trials sponsored, "Celgene" with 11 trials sponsored, "Hoffmann-La Roche" with 9 trials sponsored and "European Organisation for Research and Treatment of Cancer - EORTC" with 9 trials sponsored. Other sponsors include 192 different institutions and companies that sponsored additional 135 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sir Charles Gairdner Hospital" #1 collaborator was "National Health and Medical Research Council, Australia" with 11 trials as a collaborator, "Sir Charles Gairdner Hospital" with 8 trials as a collaborator, "NCIC Clinical Trials Group" with 6 trials as a collaborator, "Australasian Gastro-Intestinal Trials Group" with 4 trials as a collaborator and "Australasian Leukaemia and Lymphoma Group" with 4 trials as a collaborator. Other collaborators include 275 different institutions and companies that were collaborators in the rest 209 trials.

According to Clinical.Site data, the most researched conditions in "Sir Charles Gairdner Hospital" are "Prostate Cancer" (8 trials), "Melanoma" (7 trials), "Ovarian Cancer" (7 trials), "Neoplasms" (6 trials) and "Breast Cancer" (5 trials). Many other conditions were trialed in "Sir Charles Gairdner Hospital" in a lesser frequency.

Most popular intervention types in "Sir Charles Gairdner Hospital" are "Drug" (191 trials), "Radiation" (31 trials), "Other" (28 trials), "Device" (23 trials) and "Biological" (19 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (39 trials), "Gemcitabine" (10 trials), "Cisplatin" (9 trials), "Carboplatin" (8 trials) and "Lenalidomide" (7 trials). Other intervention names were less common.

The vast majority of trials in "Sir Charles Gairdner Hospital" are 229 trials for "All" genders, 17 trials for "Female" genders and 10 trials for "Male" genders.

Currently, there are NaN active trials in "Sir Charles Gairdner Hospital". undefined are not yet recruiting, 47 are recruiting, 43 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 129 completed trials in Sir Charles Gairdner Hospital, 1 suspended trials, and 20 terminated clinical trials to date.

Out of the total trials that were conducted in Sir Charles Gairdner Hospital, 28 "Phase 1" clinical trials were conducted, 75 "Phase 2" clinical trials and 120 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 30 trials that are defined as “Not Applicable".

Sir Charles Gairdner Hospital has several departments that took part in Clinical trials: "Perth Children's Hospital" - 90 trials, "Fiona Stanley Hospital; FSH Cancer Centre Clinical Trials Unit" - 4 trials, "Department of Medical Oncology" - 4 trials, "Perth Radiation Oncology" - 2 trials, "Fiona Stanley Hospital; Advanced Lung Disease Unit" - 2 trials